A SPAC I Acquisition Corp.
ASCA
NASDAQ Capital Market3.01
USD
-6.15
- -
CIK
0001868775
ISIN
VGG0542S1065
CUSIP
G0542S106
Return %
Stock
S&P500
1Y
-71.11
26.53
3Y
-69.38
76.60
5Y
-69.38
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Sze Wai Tsang CFA
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- Marina Bay Financial Centre Singapore Singapore 018983
- IPO Date
- Mar 18, 2022
- CIK
- 0001868775
- Similar Companies
- Business
- A SPAC I Acquisition Corp. (NASDAQ: ASCA) is a blank check company sponsored by A SPAC (Holdings) Acquisition Corp. that focuses on effecting mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with one or more businesses, primarily targeting opportunities in Asia; it offers no current products or services beyond its SPAC structure for capital raising through initial public offerings and trust-held funds pending de-SPAC transactions. Founded in 2021 and headquartered in Singapore, the company completed its initial public offering of 6 million units at $10 each in late 2021, raising $60 million, and operated geographically with a focus on Southeast Asia and emerging markets. In April 2024, A SPAC I completed a business combination with NewGenIvf Group Limited, a fertility services provider offering infertility treatments, assisted reproductive technologies, egg and sperm donation, and surrogacy through clinics in Thailand, Cambodia, and Kyrgyzstan; the merged entity trades as NewGenIvf Group Limited (NASDAQ: NIVF) with warrants under NIVFW, marking the SPAC's primary strategic shift and delisting of ASCA from Nasdaq.
NewGenIvf and A SPAC I Announce Closing of Business Combination
NewGenIvf and A SPAC I Announce Shareholder Approval of Business Combination